Join Us for the Bayer Expert Monday Series!
Attention Innovators and Early Stage Entrepreneurs!
Bayer is excited to host the 2025 Bayer Expert Monday series, designed specifically for innovative minds in the life sciences. This virtual series provides you with exclusive access to Bayer experts who will share their invaluable insights, experiences, and guidance to help you navigate the complexities of pharmaceutical development.
If you are an early stage entrepreneur, work with startups, or interested in advancing your knowledge in pharmaceutical development, particularly in oncology, cell and gene therapy, cardiovascular/renal, and immunology, secure your spot and register today! Don’t miss this opportunity to learn from the best and elevate your entrepreneurial journey! We look forward to seeing you at our first session and supporting your mission to innovate in the pharmaceutical industry!
What to Expect:
- Expert Insights: Each session will feature a leading expert from Bayer, covering a range of topics including drug discovery, regulatory pathways, clinical trials, and commercialization strategies, with a focus on our strategic areas of interest: oncology, cell and gene therapy, cardiovascular/renal, and immunology.
- Interactive Q&A: Engage directly with our experts during live Q&A sessions, allowing you to ask your most pressing questions and gain tailored advice for your entrepreneurial journey.
- Networking Opportunities: Connect with fellow early stage entrepreneurs and build valuable relationships within the pharmaceutical community.
Session topic: Ingredients to Success: How to Measure, Evaluate and Drive the Success of Partnerships?
Join Nicolas Becker and Joao Schumann to discover actionable strategies on effectively assessing and accelerating the impact of strategic partnerships in the global pharmaceutical landscape.
Nicolas Becker
Sr. Director Business Development & Licensing / Alliance Management
Bayer Pharmaceuticals
With 24 years of experience in the pharmaceutical industry, Nicolas Becker is a seasoned expert in Business Development, Licensing, and Alliance Management. He has a strong track record of successfully negotiating and executing collaborations, as well as managing strategic alliances across mid- to late-stage R&D, commercial partnerships, and M&A transactions.
Combining deep analytical and financial expertise with a self-driven, results-oriented approach, Nicolas brings extensive cross-cultural leadership experience to his work. Having lived and worked in both Asian and European markets, he offers a global perspective and refined strategic insight that enhance his ability to lead complex, high-impact initiatives across geographies.
Joao Schumann
Alliance Manager
Bayer Pharmaceuticals
Joao Schumann is a results-driven senior leader with 20 years of international experience in the pharmaceutical industry. His career spans alliance management, business development and licensing, marketing, sales, and leading sub-regional and country organizations. Known for his strong communication skills and ability to energize teams, Joao consistently drives success by implementing customer-oriented strategies and fostering a culture of innovation and accountability.
He has a proven track record of challenging the status quo, spearheading impactful initiatives, and securing alignment from internal and external stakeholders to exceed growth targets. With broad experience across local, regional, and global roles in Europe, the Americas, and Asia, Joao brings a global perspective and deep strategic insight to every endeavor.
What you need to know:
- Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts.
- These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey.
- Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.
- Each session has a maximum capacity of 500 participants.
Interested in hearing from more experts? There are more sessions to come, so be sure to click here for updates!